Nektar melanoma in IO treatment naive patients | IDRA Message Board Posts

Idera Pharmaceuticals, Inc

  IDRA website
  • Reminder to Premium Members: To enjoy full site functionality & avoid the bugs currently affecting recommend, delete & other features on our "www" pages, please log in to your premium accounts at https://premium.investorvillage.com If you need assistance, don't hesitate to contact customer support any time. That's a big part of what you pay for, after all!  


IDRA   /  Message Board  /  Read Message

 

 






Keyword
Subject
Between
and
Rec'd By
Authored By
Minimum Recs
  
Previous Message  Next Message   Post Message   Post a Reply return to message boardtop of board
Msg  1444 of 1484  at  6/17/2019 12:15:30 PM  by

vinyl


 In response to msg 1443 by  raferjack
view thread

Re: Nektar melanoma in IO treatment naive patients

as always rafer I appreciate your sharing your knowledge and input.I have speculated in biotech going back to Genentech who at the time was 25 perc owned by the cath church---I am still in idra and will remain.I hate to sound vindictive but did not shed a tear for bcrx shareholders----only for those that will not benefit from the treatment. I was given ziop recently and bought it on the chart.My source is in love with situation and averaged down from 7.Being experienced in the plusses and minuses of speculating in bio--and having no knowledge of the many evolving platforms ,I find it hard to accumulate large positions.I cant help but wonder if the proposed merger would have worked out.thx again,and good luck to all of idra longs


     e-mail to a friend      printer-friendly     add to library      
| More
Recs: 1     Views: 104
Previous Message  Next Message   Post Message   Post a Reply return to message boardtop of board


About Us    Contact Us    Follow Us on Twitter    Members Directory    Help Center    Advertise
Not a member yet? What are you waiting for? Create Account
Want to contribute? Support InvestorVillage by donating
2003-2018 Investorvillage.com. All rights reserved. User Agreement
   
Financial Market Data provided by
.


Loading...